Invesaro
Investment thesis · Live

America has fired off its missile stockpile on three fronts, and the bottleneck for rebuilding it is two rocket motor plants

Three simultaneous fronts have drained US interceptor inventories, and the pace of the rebuild is capped by a duopoly in rocket motors: the value accrues to the bottleneck.

Published August 5, 2026 · 150-day horizon · supply and demand

Basket return
-4.0%
equal weight, since publication
The market over the same window
-0.2%
benchmark for this basket
Edge over the market
-3.8%
in percentage points
Causal chain: Defense on three fronts: Israel, Red Sea, Ukraine → Interceptor inventories nearly empty → Multi-year wave of restocking orders → Bottleneck: rocket motors (duopoly) → Interceptor primes: LMT, RTX → Motor chokepoint: LHX (Aerojet), NOC

What this thesis rests on

Each one is a statement that has to be true. We go back to every live thesis on a schedule and check these against public sources, so each leg carries either what we found or the date we look next.

Checked every 14 days. Last review August 28, 2026, next one September 11, 2026.

  1. Through 2 January 2027, no third supplier beyond L3Harris (Aerojet Rocketdyne) and Northrop Grumman is qualified to deliver solid rocket motors for PAC-3 MSE, THAAD, SM-3 or SM-6.

    competitive · Open

    Checked August 28, 2026, nothing published either way

  2. Lockheed Martin keeps its PAC-3 MSE ramp toward 650 units per year, reporting no reduction in annual interceptor delivery targets in its next two quarterly filings.

    operational · Supported

    Checked August 28, 2026, nothing published either way

  3. RTX reports total company backlog at each of the two quarterly reports after publication that is higher than the level reported for the quarter ended 30 June 2026.

    financial · Open

    Checked August 28, 2026, nothing published either way

  4. L3Harris reports Aerojet Rocketdyne (Aerojet segment) revenue growth of at least 10% year over year in each of the two quarters reported after publication.

    financial · Open

    Checked August 28, 2026, nothing published either way

  5. Congress enacts full-year FY2027 defense appropriations rather than a full-year continuing resolution before 2 January 2027, permitting new missile procurement starts.

    regulatory · Challenged

    Checked August 28, 2026, nothing published either way

Over the past several quarters America has been running missile defense on three fronts at once: shielding Israel from ballistic missiles, shooting down Houthi drones and rockets over the Red Sea, and supplying interceptors to Ukraine. Wire reports state plainly that the missile stockpile is nearly exhausted, and while Washington denies it, the direction of travel is not in dispute: inventories of the most expensive interceptors (THAAD, Patriot, SM-3, SM-6) are now badly depleted and will have to be rebuilt.

The key observation, still underappreciated, is this: a defense budget can be raised in a matter of weeks, but an interceptor cannot be built any faster. The physical bottleneck in the entire chain is the solid rocket motor. Western production of these motors has shrunk to effectively two suppliers, and adding capacity takes years. That means restocking will stretch out over many years and will keep order books full far longer than any single escalation episode would suggest.

This thesis, over time

What has happened since publication. Every entry is computed as of its own date, from price history.

August 28, 2026

Review on day 23: nothing moved

We went back to this thesis on day 23 of 150 and checked each of its 5 assumptions against public sources. No news either way: 5. The equal-weight basket stands at -4.0% since publication day. The benchmark (.INX) returned +0.1% over the same window, so the basket trails its market by 4.1 percentage points. 127 days remain until the verdict.

Open the interactive thesis

Interactive causal map, the basket charted against its market, and the full timeline.

Open in Invesaro →

New theses straight to your inbox

Subscribe and we will send you every new thesis and every verdict. No spam, one-click unsubscribe.

This is analysis, not investment advice and not a recommendation to buy or sell anything. We publish it and track it in public, mistakes included. Any decision is yours and yours alone.